Lactucopicrin: A Sesquiterpene Lactone with Anti-Inflammatory Activity Modulates the Crosstalk between NF-kB and AHR Pathways
Open Access
- 4 November 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (21) , 23406-23420
Abstract
Chronic inflammatory diseases, including inflammatory bowel diseases and cardiovascular diseases, share inflammation as a central pathological feature. The transcription factors NF-kB and AHR are key regulators of inflammatory responses, yet their interplay remains underexplored in the context of natural anti-inflammatory compounds. This study investigates the anti-inflammatory properties of sesquiterpene lactones derived from Cichorium intybusL. (chicory), focusing on their modulation of NF-kB and AHR signaling pathways. Using a TNFα-induced inflammation model in macrophages, endothelial, and intestinal epithelial cells, we identified lactucopicrin as a potent NF-kB antagonist. Notably, in silico docking and functional assays revealed lactucopicrin as a novel AHR modulator. Crucially, silencing AHR expression attenuated lactucopicrin-mediated NF-kB inhibition, uncovering a previously unrecognized AHR-NF-kB crosstalk mechanism. These findings not only position lactucopicrin as a dual-pathway modulator but also highlight the therapeutic potential of chicory-derived sesquiterpene lactones in treating inflammation-driven diseases, opening new avenues for leveraging natural products in targeted anti-inflammatory strategies.Keywords
All Related Versions
Funding Information
- European Commission (COMPETE2030-FEDER-00693400)
- European Commission (NORTE2030-FEDER-01777300 - SCALE-ImmunoHUB2030)
- Ludwig Institute for Cancer Research
- Ministério da Ciência, Tecnologia e Ensino Superior
- Horizon 2020 Framework Programme (760891)
- Horizon 2020 Framework Programme (951921)
- Fundação para a Ciência e a Tecnologia (2022.11465.BD)
- Fundação para a Ciência e a Tecnologia (2023.00453.BD)
- Fundação para a Ciência e a Tecnologia (2023.02417.BD)
- iNOVA4Health (LISBOA-01-0145-FEDER-007344)
- iNOVA4Health (UIDB/04462/2020)
- European Regional Development Fund (FEDER) (COMPETE2030-FEDER-00693400)
- European Regional Development Fund (FEDER) (NORTE2030-FEDER-01777300 - SCALE-ImmunoHUB2030)
This publication has 83 references indexed in Scilit:
- The role of gut microbiota, immune system, and autophagy in the pathogenesis of inflammatory bowel disease: Molecular mechanisms and therapeutic approachesAspects of Molecular Medicine, 2024
- Small molecule α-methylene-γ-butyrolactone, an evolutionarily conserved moiety in sesquiterpene lactones, ameliorates arthritic phenotype via interference DNA binding activity of NF-κBActa Pharmaceutica Sinica B, 2024
- Lactucopicrin Inhibits Cytoplasmic Dynein‐Mediated NF‐κB Activation in Inflammated Macrophages and Alleviates Atherogenesis in Apolipoprotein E‐Deficient MiceMolecular Nutrition & Food Research, 2020
- Human Gut Microbiota Metabolism of Dietary Sesquiterpene Lactones: Untargeted Metabolomics Study of Lactucopicrin and Lactucin Conversion In Vitro and In VivoMolecular Nutrition & Food Research, 2020
- The Aryl Hydrocarbon Receptor (AHR) as a Potential Target for the Control of Intestinal Inflammation: Insights from an Immune and Bacteria Sensor ReceptorClinical Reviews in Allergy & Immunology, 2020
- ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesisJournal of Leukocyte Biology, 2020
- Palmitoleic Acid has Stronger Anti‐Inflammatory Potential in Human Endothelial Cells Compared to Oleic and Palmitic AcidsMolecular Nutrition & Food Research, 2018
- Susceptibility to chronic inflammation: an updateArchives of Toxicology, 2017
- Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell linesMolecular Carcinogenesis, 2010
- TCDD-Inducible Poly(ADP-ribose) Polymerase: A Novel Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxinBiochemical and Biophysical Research Communications, 2001